Top of the morning to you, and a fine one it is. A shiny sun and crisp breeze are enveloping the Pharmalot campus, where the short people have left for the local schoolhouse and gainful employment, respectively, leaving us with the official mascot to sort out the morning routine. And of course, this means we are, once again, firing up the coffee kettle for a cup of stimulation. And why not? The neurons can use a little help. Feel free to join us if you agree. Meanwhile, time to get cracking. Here are some items of interest. Hope you have a splendid day and, as always, do keep in touch. …

The Food and Drug Administration plans to provide “concierge service” to doctors seeking access to unapproved drugs for cancer patients who have no other treatment options, The Washington Post writes. The pilot will include Project Facilitate, a new call center run by the agency’s oncology staff to provide a single point of contact for doctors submitting requests for the program. Although the agency has streamlined its expanded-access program in recent years, the process still may seem confusing to doctors who have little experience with it.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy